Protox Therapeutics (PRX:TSX)

ENLARGE

Protox Therapeutics (PRX:TSX) - 10/28/2008
Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases.

Stock Chart

Recent Headlines

Protox announces positive six month phase 2b BPH results (CNW Group) [6/2/2010]
Protox to present Phase 2b BPH data at the Annual Meeting of the American Urological Association (CNW Group) [6/1/2010]
Protox reports first quarter 2010 financial results (CNW Group) [5/13/2010]

Yahoo! Finance RSS

FEATURES
FEATURED THIS WEEK
FEATURED COMPANIES
TESTIMONIALS

EMAIL THIS PAGE

Join Our Mailing List
Sign up to receive our Newletter and other important updates

Submit Your Profile
Now booking for spring 2010 episodes in various sectors

Subscribe to Our RSS
Sign up to the BTV RSS Feed for up to the munite updates and content

Follow Us on Twitter
Add us to your account to receive up to the second updates wherever you are